Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC
Clinical trial NCT06599827 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06599827
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-20
- Primary completion
- 2026-09-20
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.